Abstract P4-09-29: PR status cannot predict Oncotype DX Recurrence Score®: a study in a Greek cohort of N0M0/ER+/PR-/HER2- breast cancer patients tested with Oncotype DX
Year: 2025
Type: conference-abstract
Source: Clinical Cancer Research
Authors: Vasileios Venizelos, Rodoniki Iosifidou, Christos Markopoulos, Gregory Xepadakis, Nikolaos Tsoulos, Spiridon Giannoulakis, Georgios Kapetsis, Amanta Psyrri, Zacharenia Saridaki, Ioannis Natsiopoulos, Adamantia Nikolaidi, Aikaterini Savvidou, Anastasios Mpoutis, Ioannis Mpoukovinas, Athanasios Kotsakis, Athina Christopoulou, Emmanouil Saloustros, Dimitrios Mavroudis, Sofia Aggelaki, Avraam Assi, Dimitrios Tzanninis, Dimitrios Grosomanidis, Elena Fountzila, Efthalia Lala, Eeleftheria Ignatiadou, Maria Skondra, Flora Zagouri, Anna Koumarianou, Paris Kosmidis, Stergios Douvetzemis, Konstantinos Papazisis, Kornilia Anastasakou, Foteini Pavlidou, Eleftherios Kampletsas, Fiorita Poulakaki, Georgios Simpilidis, Sofia Triantafillidou, Maroulio Stathoulopoulou
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4411289652